Genetic testing could help smokers quit

09/26/2007 | M.I.T. Technology Review

Genetic testing showed that people who carry the CYP2B6*6 gene variation are more likely to benefit from the smoking-cessation drug bupropion than those who do not have the gene variation, a new study found. Researchers hope genetic testing could help doctors recommend the best treatments to individuals who want to quit smoking.

View Full Article in:

M.I.T. Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA